The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(4-(2-(2-hydroxy-2-(pyridin-3-yl)ethylamino)ethyl)phenyl)-2-(pyrrolidin-1-yl)benzamide ID: ALA1089735
PubChem CID: 46881902
Max Phase: Preclinical
Molecular Formula: C26H30N4O2
Molecular Weight: 430.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1N1CCCC1
Standard InChI: InChI=1S/C26H30N4O2/c31-25(21-6-5-14-27-18-21)19-28-15-13-20-9-11-22(12-10-20)29-26(32)23-7-1-2-8-24(23)30-16-3-4-17-30/h1-2,5-12,14,18,25,28,31H,3-4,13,15-17,19H2,(H,29,32)/t25-/m0/s1
Standard InChI Key: OAFWFJPMALLJIG-VWLOTQADSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
10.1819 -20.7583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1807 -21.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8956 -21.9985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6120 -21.5852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6091 -20.7547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8938 -20.3455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3221 -20.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0381 -20.7493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3189 -19.5145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7510 -20.3341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4670 -20.7439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1799 -20.3287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8959 -20.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8962 -21.5636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6113 -21.9733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3252 -21.5581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3195 -20.7288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6037 -20.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0418 -21.9669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7542 -21.5508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7500 -20.7258 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4707 -21.9596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4723 -22.7844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1880 -23.1932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9013 -22.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8944 -21.9478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1782 -21.5427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1708 -20.7177 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8295 -20.2286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5675 -19.4463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7425 -19.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4947 -20.2406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15 16 2 0
7 8 1 0
16 17 1 0
17 18 2 0
18 13 1 0
7 9 1 1
16 19 1 0
4 5 1 0
19 20 1 0
8 10 1 0
20 21 2 0
2 3 1 0
20 22 1 0
10 11 1 0
22 23 2 0
5 6 2 0
23 24 1 0
11 12 1 0
24 25 2 0
6 1 1 0
25 26 1 0
12 13 1 0
26 27 2 0
27 22 1 0
1 2 2 0
27 28 1 0
28 29 1 0
13 14 2 0
5 7 1 0
14 15 1 0
3 4 2 0
29 30 1 0
30 31 1 0
31 32 1 0
32 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 430.55Molecular Weight (Monoisotopic): 430.2369AlogP: 3.80#Rotatable Bonds: 9Polar Surface Area: 77.49Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.87CX Basic pKa: 9.45CX LogP: 3.30CX LogD: 1.27Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -1.29
References 1. Goble SD, Wang L, Howell KL, Bansal A, Berger R, Brockunier L, DiSalvo J, Feighner S, Harper B, He J, Hurley A, Hreniuk D, Parmee E, Robbins M, Salituro G, Sanfiz A, Streckfuss E, Watkins E, Weber AE, Struthers M, Edmondson SD.. (2010) Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles., 20 (6): [PMID:20181479 ] [10.1016/j.bmcl.2010.01.130 ]